FDA approves BOTOX as prophylactic treatment for Chronic Migraine

Published October 18, 2010

FDA approves BOTOX as prophylactic treatment for Chronic Migraine
Allergan, Inc. today announced the United States Food and Drug Administration (FDA) has approved BOTOX(onabotulinumtoxinA) for the prophylactic (preventive) treatment of headaches in adults with Chronic Migraine.
Read more on News-Medical-Net

FDA approves ISTA’s sNDA for BROMDAY anti-inflammatory drug
ISTA Pharmaceuticals, Inc. today announced the U.S. Food and Drug Administration (FDA) has approved the Company’s supplemental New Drug Application (sNDA) for BROMDAY (bromfenac ophthalmic solution) 0.09% as a once-daily prescription eye drop for the treatment of postoperative inflammation and reduction of ocular pain in patients who have undergone cataract extraction.
Read more on News-Medical-Net

Prison Drug Treatment Would Reduce Overcrowding, Crime, Budgets Say Robert Weiner, Ex-White House Drug Spokesman …
Deficit Commission Should Heed Savings
Read more on PR Newswire via Yahoo! News